CWM
RVMD icon

Centric Wealth Management’s Revolution Medicines RVMD Stock Holding History

Centric Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Hold
3,416
– – 0.08% 139
2026
Q1 		$505K Hold
3,416
– – 0.1% 129
2025
Q4 		$332K Buy
+3,416
New +$224K 0.07% 155

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Centric Wealth Management's RVMD Position: Q2 2026 in Review

Centric Wealth Management held its Revolution Medicines (RVMD) position steady in Q2 2026 at 3,416 shares worth $505K. The position accounts for 0.08% of the portfolio, ranked #139.

Centric Wealth Management first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Centric Wealth Management held 3,416 shares of Revolution Medicines worth $505K as of Q2 2026.
  • Centric Wealth Management left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up 0.08% of Centric Wealth Management's portfolio in Q2 2026, its #139 holding.
  • Centric Wealth Management first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Centric Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.